Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Institut Curie
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
St. Anna Kinderkrebsforschung
Children's Oncology Group
University of Cologne
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
Northwestern University